Align Technology (ALGN) is a publicly traded Healthcare sector company. As of October 28, 2026, ALGN trades at $152.11 with a market cap of $10.79B and a P/E ratio of 24.68. ALGN moved +0.92% today. Year to date, ALGN is -1.54%; over the trailing twelve months it is +15.38%. Its 52-week range spans $122.00 to $208.31. Analyst consensus is buy with an average price target of $194.90. Rallies surfaces ALGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ALGN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $152.11 |
| Market Cap | $10.79B |
| P/E Ratio | 24.68 |
| EPS | $5.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $208.31 |
| 52-Week Low | $122.00 |
| Volume | 1.10M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.14B |
| Net Income | $413.58M |
| Gross Margin | 68.05% |
13 analysts cover ALGN: 0 strong buy, 8 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $194.90.